Genome ‐wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients
In conclusion, we identified AML methylation subtypes and their marker genes, these results may help to excavate potential targets for clinical therapy and the development of precision medicine for AML patients.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Haiyan Gao,
Xin He,
Qiang Li,
Ying Wang,
Yaoyao Tian,
Xi Chen,
Jinghua Wang,
Yan Guo,
Wei Wang,
Xiaoyun Li Tags: ORIGINAL RESEARCH Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Genetics | Leukemia | Lymphoma | Study